NCT02500706 Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT02490787 Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects Status COMPLETED Phase PHASE1
NCT02486419 Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study. Status COMPLETED Phase N/A
NCT02486237 Complications in Central American Diabetic Patients: Historic Cohort Status COMPLETED Phase N/A
NCT02479022 A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02473809 The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function Status COMPLETED Phase PHASE4
NCT02472717 Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study Status WITHDRAWN Phase PHASE2
NCT02470039 Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy Status COMPLETED Phase PHASE2
NCT02461589 Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02453711 Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02453685 A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT02443155 A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function Status COMPLETED Phase PHASE2
NCT02420262 A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02408705 Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects Status COMPLETED Phase PHASE2
NCT02403284 The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans Status COMPLETED Phase PHASE4
NCT02392117 Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02382939 A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency Status COMPLETED Phase PHASE3